|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-29.52/-2.83
|
企业价值
41.12M
|
资产负债 |
每股账面净值
0.14
|
现金流量 |
现金流量率
--
|
损益表 |
收益
27.51M
|
每股收益
18.60
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/14 03:26 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services. |